Website Changes
11/12/2022
Candel Therapeutics Announces Late-Breaking Oral Presentation at SITC Annual Meeting
11/11/2022
Alpheus Medical Treats First Patients in First-In-Human Clinical Trial for Novel High-Grade Glioma Brain Cancer Treatment
11/11/2022
Novocure Secures CE Mark for New Array
11/11/2022
Concurrent chemoradiation and Tumor Treating Fields (TTFields, 200 kHz) for patients with newly diagnosed glioblastoma: patterns of progression in a single institution pilot study
11/09/2022
Starting with ADC, FDA calls for fully enrolled confirmatory trial prior to accelerated approval submission
11/09/2022
Navigating Emotional Wellbeing as a GBM Caregiver: A Conversations with Mental Health Experts
11/08/2022
Step taken towards non-surgical treatment for schwannomas
11/07/2022
Reminder: Webinar tonight (11/7/22 at 7pm Eastern) on Sonodynamic Therapy for Brain Tumors
11/04/2022
OKN-007 Expanded Access for Pediatric Patients with Diffuse Midline Glioma(including DIPG)
11/04/2022
Finally, cancer patients have real-time access to their medical records
11/04/2022
Webinar on Sonodynamic Therapy for the Treatment of Malignant Glioma to be presented Monday, Nov 7, 2022
10/27/2022
Walmart.com selects the Musella Foundation for it`s new charity program!
10/27/2022
Webinar on Sonodynamic Therapy for the Treatment of Malignant Glioma to be presented Monday, Nov 7, 2022
10/27/2022
New Edition Of our Brain Tumor Guide For The Newly Diagnosed is now available!
10/25/2022
NeedyMeds Webinars
10/25/2022
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
10/25/2022
Novocure Launches Campaign to Drive Awareness and Understanding of Tumor Treating Fields Therapy
10/19/2022
Determinants of tumor treating field usage in patients with primary glioblastoma: A single institutional experience
10/17/2022
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
10/11/2022
GT Medical Technologies Announces First Patient Enrolled in GESTALT Trial of GammaTile® Therapy for Newly Diagnosed Glioblastoma Brain Tumors
10/09/2022
Video of our recent webinar posted to our website!
10/06/2022
Plus Therapeutics Announces Patient Webinar in Recognition of Breast Cancer Awareness Month
10/02/2022
Radiotherapy Plus Temozolomide With or Without Nimotuzumab Against the Newly Diagnosed EGFR-Positive Glioblastoma: A Retrospective Cohort Study
10/01/2022
Biosensor Detects Brain Tumors With Less Than a Drop of Blood
09/30/2022
Webinar on A Promising New Targeted Radiation Therapy for Leptomeningeal Metastases in Breast Cancer, Lung Cancer, and Other Malignancies
which delivers brain tumor news and additions
to the website via RSS.